Commercially available tests for determining cefiderocol susceptibility display variable performance in the Achromobacter genus
Abstract Background Cefiderocol is a siderophore-conjugated cephalosporin increasingly used in the management of Achromobacter infections. Testing for cefiderocol susceptibility is challenging with distinct recommendations depending on the pathogens. Objectives We evaluated the performance of commer...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2024-08-01
|
| Serie: | Annals of Clinical Microbiology and Antimicrobials |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s12941-024-00731-1 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
